The use of CA-IX as a diagnostic method for oral leukoplakia.

scientific article published on 9 October 2014

The use of CA-IX as a diagnostic method for oral leukoplakia. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/10520295.2014.965276
P698PubMed publication ID25297562

P50authorAbel García-GarcíaQ37837089
Mario Pérez SayánsQ43904511
Pilar Gandara VilaQ51680043
Pilar Gayoso-DizQ64683482
José Manuel Suárez-PeñarandaQ71774909
F Barros-AngueiraQ114563088
P2093author name stringC T Supuran
M Gallas-Torreira
M Torres-López
P2860cites workA novel quasi-viral agent, MaTu, is a two-component systemQ28209256
Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-upQ33447858
Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of managementQ33544076
A review of the nonsurgical treatment of oral leukoplakiaQ33720658
Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosaQ34116632
Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients.Q34632270
Progress in determining the malignant potential of oral lesionsQ35106813
Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markersQ35132130
Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristicsQ35134845
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancerQ35167920
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.Q35746400
Nomenclature and classification of potentially malignant disorders of the oral mucosaQ36974891
Natural history of potentially malignant oral lesions and conditions: an overview of the literatureQ37043659
Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvementQ37077759
The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladderQ37145181
Expression of the cell cycle regulation proteins p53 and p21WAF1 in different types of non-dysplastic leukoplakias.Q37437569
Genetic and molecular alterations associated with oral squamous cell cancer (Review).Q37626579
Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanismQ37740182
Carbonic anhydrase inhibitors and activators for novel therapeutic applicationsQ37909406
Interfering with pH regulation in tumours as a therapeutic strategyQ37933052
Hypoxia-inducible factors in OSCC.Q37940756
The role of carbonic anhydrase IX in hypoxia control in OSCC.Q37993617
Chondrosarcoma of the distal phalanx of the right great toe: report of a rare malignancy and review of literatureQ38005289
Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma.Q38395239
A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN.Q38476637
Oral leukoplakiaQ40406090
Evaluation of glutathione S-transferase activity in human buccal epithelial dysplasias and squamous cell carcinomasQ40893794
Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White LesionsQ41007002
Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferationQ42148565
MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarkerQ42439841
Monoclonal antibodies generated in carbonic anhydrase IX-deficient mice recognize different domains of tumour-associated hypoxia-induced carbonic anhydrase IX*1Q44095114
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamidesQ44366527
The clinical determinants of malignant transformation in oral epithelial dysplasia.Q44498677
Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-β: but p53 mutations are not necessarily requiredQ44637351
Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?Q45248232
Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.Q47928743
The impact of liquid-based oral cytology on the diagnosis of oral squamous dysplasia and carcinoma.Q50858057
Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation.Q53342633
Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.Q53399969
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinomaQ57377955
Genetic portrait of mild and severe lingual dysplasiaQ57765119
Salivary markers of oxidative stress in patients with oral premalignant lesionsQ57825999
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectoral mucosa leukoplakiaQ18558187
P304page(s)124-131
P577publication date2014-10-09
P1433published inBiotechnic & HistochemistryQ4915326
P1476titleThe use of CA-IX as a diagnostic method for oral leukoplakia
P478volume90

Reverse relations

cites work (P2860)
Q64974608Determination and diagnostic value of CA9 mRNA in peripheral blood of patients with oral leukoplakia.
Q93015783Dissecting the Proton Transport Pathway in Oral Squamous Cell Carcinoma: State of the Art and Theranostics Implications

Search more.